TMS Therapy Cost With and Without Insurance: What to Verify

What you are paying for

A TMS course is a series of billed sessions, not one procedure.

The FDA classified repetitive TMS systems in 2008 as prescription devices for adults with major depressive disorder who did not get satisfactory improvement from at least one prior antidepressant in the current episode. The treatment is delivered as daily outpatient sessions, and each session is billed.

NIMH describes a typical course as daily sessions five days a week for four to six weeks. The Clinical TMS Society consensus review describes the same daily high-frequency left-prefrontal schedule, with benefit building gradually over that period, followed by a slow taper over about three weeks (three sessions the first week, then two, then one).

Insurers translate that into a session cap. Aetna’s policy, for example, states that treatment consists of a maximum of 30 sessions (five days a week for six weeks) plus 6 tapering sessions over three weeks, with anything beyond 36 sessions needing separate medical-necessity review. Three procedure codes usually appear on the bill: an initial session that includes cortical mapping and motor-threshold determination (CPT 90867), each subsequent session (CPT 90868), and any later motor-threshold re-determination (CPT 90869).

Cost without insurance

Self-pay pricing is set by each clinic; verify the course total, not the headline.

No manufacturer, agency, or professional body publishes a national self-pay price for TMS. Both major device makers say only that cost varies with the plan, the condition, and the number of sessions, and that financing may be offered.

The most defensible public benchmark is what Medicare pays. A 2017 peer-reviewed cost-effectiveness analysis in PLOS ONE used the published 2016 Medicare national average payment of $206 per subsequent rTMS session (CPT 90868). At that rate, 36 sessions would total roughly $7,400 before the initial mapping session, psychiatric evaluation, follow-up visits, or any re-mapping. That is an illustration of a dated public rate, not a price; clinic self-pay rates are set locally and may sit above or below it, and current Medicare amounts differ by year and locality.

Websites that publish self-pay ranges, including the ones that appear in search results, are quoting their own or a competitor’s marketing numbers. Treat every figure as a prompt for one question: what is the written, itemized total for my full course at this clinic?

Number of sessions

A standard course billed to insurers is capped by many plans at 30 daily sessions plus 6 taper sessions. Clinics may quote a per-session price, a course price, or both. Ask which sessions the quote includes and what each additional session costs.

Protocol and device

Standard repetitive TMS, deep TMS, theta-burst, accelerated, and MRI-guided protocols use different devices, session counts, and billing codes. Accelerated and MRI-guided theta-burst protocols carry their own codes and are treated as experimental by at least one major insurer, which usually means self-pay.

Motor-threshold mapping

The first session includes cortical mapping and motor-threshold determination, which is billed differently from a routine session. Re-determinations during the course may be billed again.

Evaluation and supervision

Medicare contractors require the order to come from a psychiatrist who examined the patient and require treatment under direct physician supervision. Psychiatric evaluation, rating scales, and follow-up visits can be billed separately from the stimulation itself.

Where you sit in your deductible

With insurance, the same 36 sessions can cost very different amounts depending on whether the deductible has been met, whether cost-sharing is a flat copay or a percentage, and whether the clinic and supervising physician are both in network.

Retreatment and maintenance

Plans that cover a first course set separate rules for retreatment, often requiring a documented response to the earlier course and a waiting period. Maintenance schedules are frequently not covered at all.

Cost with insurance

Your out-of-pocket number comes from plan design and medical-necessity criteria.

Coverage happens in two steps: the plan decides whether the course is medically necessary under its written policy, then your benefit design decides what you pay per visit. Both steps need answers in writing before the first session.

Commercial criteria are specific. Aetna’s bulletin requires members to be 15 or older; adults must show inadequate response to two antidepressants from at least two different classes, each used for at least eight weeks, plus an augmentation trial for at least eight weeks. Retreatment is allowed for relapse if the earlier course produced at least a 50 percent reduction in symptoms lasting at least two months, and is considered not medically necessary within 60 days of the prior course. Other plans use their own thresholds; your plan’s policy document is the one that counts.

Once approved, the cost is arithmetic you can do in advance. Ask the plan for the cost-sharing that applies to codes 90867, 90868, and 90869 at this clinic: a flat copay per visit, or a coinsurance percentage after the deductible. Multiply by the authorized number of sessions, add the supervising psychiatrist’s evaluation and follow-up visits, and compare the result with the plan’s out-of-pocket maximum. Confirm that the clinic, the supervising physician, and the facility are each in network; a single out-of-network party can change the whole calculation.

Payment lane	What decides the cost	What to get in writing
Self-pay	The clinic’s own rate card, protocol, session count, and what the quote includes.	Itemized course total, per-session price, mapping and re-mapping charges, evaluation and follow-up fees, cancellation and refund terms, financing conditions.
Commercial or exchange plan	The plan’s medical-necessity policy, prior authorization, network status, and your deductible, copay or coinsurance, and out-of-pocket maximum.	Authorization reference number and session count, in-network confirmation for clinic and physician, per-visit cost-sharing by code, remaining deductible, appeal deadline if denied.
Original Medicare (Part B)	The regional contractor’s Local Coverage Determination, plus the Part B deductible and 20 percent coinsurance on the Medicare-approved amount.	Which LCD applies in your state, whether the clinic accepts assignment, whether the ordering psychiatrist examined you, and any supplemental (Medigap) coverage of the 20 percent.
Medicare Advantage	The plan’s own prior-authorization process and cost-sharing, within Medicare coverage rules.	Written authorization, in-network status, per-visit cost-sharing, and the plan’s out-of-pocket limit.
Medicaid	State program or managed-care plan policy, which differs by state.	The specific state or plan policy for TMS, prior-authorization requirements, and any enrolled-provider restrictions.

Medicare specifics

Medicare covers TMS through regional rules, not one national decision.

Medicare Administrative Contractors publish Local Coverage Determinations for TMS. They set who can be treated, who must order and supervise, and when retreatment is allowed. The rules differ by contractor, so the LCD for your state is the document to read.

As one example, the Wisconsin Physicians Service LCD L34641 (revision effective March 26, 2026) covers adults with a confirmed diagnosis of severe major depressive disorder who meet at least one of several criteria, including lack of a clinically significant response to medication trials from at least two different agent classes in the current episode, or inability to tolerate medications from two classes, with a trial of evidence-based psychotherapy of adequate frequency and duration without significant improvement. The order must be written by a psychiatrist (MD or DO) who examined the patient, and treatment must be given under that physician’s direct supervision. Retreatment is allowed for relapse when the earlier course produced greater than 50 percent improvement on a standard rating scale. Exclusions include a seizure disorder, psychotic symptoms, certain neurological conditions, and implanted magnetic-sensitive devices within 30 centimeters.

On the cost side, Medicare.gov states that in 2026 you pay a $283 Part B deductible once each year and then usually 20 percent of the Medicare-approved amount for each covered service after the deductible. Across a multi-week course that 20 percent adds up, so ask whether a Medigap or retiree plan covers it.

Accelerated, deep, and MRI-guided protocols

A different protocol is a different bill.

Accelerated and MRI-guided theta-burst protocols use their own procedure codes, and at least one major commercial policy lists them as experimental and investigational, which usually means self-pay.

UnitedHealthcare’s 2026 commercial policy lists category III codes 0889T through 0892T for accelerated, high-dose, functional-connectivity MRI-guided theta-burst stimulation, separate from the 90867 to 90869 codes for standard repetitive TMS. Aetna’s bulletin covers intermittent theta-burst stimulation delivered on an FDA-cleared device under its standard criteria, but lists accelerated TMS and MRI-guided TMS, including SAINT, as experimental and investigational for depression. If a clinic offers a five-day or imaging-guided course, ask for the exact device, protocol, and codes it will bill, and ask the plan in writing whether those codes are covered. The SAINT cost and insurance guide covers that protocol in detail.

Printable verification worksheet

Use one record for the clinic and the plan.

Record the date, representative, reference number, and exact answer for every cost and coverage conversation. Keep completed health and insurance details with your care team; do not send them to Advanced Depression Care.

Device and protocol (standard rTMS, deep TMS, theta-burst, accelerated, MRI-guided):

Ordering psychiatrist and supervising physician:

Authorized or planned number of sessions, including taper:

Self-pay course total and per-session price, if applicable:

Initial mapping (90867), subsequent session (90868), and re-mapping (90869) charges:

Evaluation, rating-scale, and follow-up visit charges:

In-network status for clinic, physician, and facility:

Prior-authorization requirement, reference number, and approved session count:

Remaining deductible, per-visit copay or coinsurance, out-of-pocket maximum:

Medicare LCD or plan policy name and retreatment rules:

Written-denial and appeal deadline, if applicable:

Cancellation, refund, and financing terms:

Review care-finding resources

Provider questions

Ask these questions before scheduling or paying.

Which device and protocol will I receive, and which procedure codes will be billed for each session?
Which psychiatrist examined me and wrote the order, and who supervises each session?
How many sessions are planned, including taper, and what happens to the price if I stop early or need more?
What is the written, itemized total for the full course if I pay myself?
Which plan criteria did you document for my prior authorization, and what was approved?
Are the clinic, the supervising physician, and the facility each in network with my plan?
What is my per-visit cost-sharing, and how does my remaining deductible change the total?
If a claim or authorization is denied, who files the appeal and by when?
What are your retreatment and maintenance policies, and are they covered?
What alternatives remain if TMS is not appropriate, approved, or affordable for me?

Candidacy and risk

Coverage criteria are not a clinical assessment.

Meeting an insurer’s written criteria does not make TMS the right choice, and failing them does not always rule it out. The FDA-cleared indication covers adults with major depressive disorder who did not improve on prior antidepressant treatment in the current episode; NIMH notes a 2024 clearance extending adjunctive use to adolescents 15 and older. Policy exclusions such as seizure history, ferromagnetic implants near the head, and unstable medical illness exist for safety reasons. NIMH lists scalp discomfort, mild headache, brief lightheadedness, and dizziness as common side effects, and the Clinical TMS Society consensus review describes seizure as rare. A qualified treating clinician must assess diagnosis, history, medications, contraindications, and safety needs.

Common questions

TMS cost and insurance questions

How much does TMS cost without insurance?

There is no verified nationwide self-pay price. Clinic websites publish widely different totals, and those are marketing figures rather than quotes. One published benchmark is the Medicare national average payment of $206 per subsequent session (CPT 90868) used in a 2017 peer-reviewed cost analysis based on 2016 rates. At that rate a 36-session course would be roughly $7,400 before evaluation, mapping, and follow-up charges; a clinic’s self-pay price can be higher or lower. Ask for a written, itemized estimate for the full course.

How expensive is TMS with insurance?

It depends on the plan’s cost-sharing design, not on TMS itself. Multiply your per-visit copay or coinsurance by the expected number of sessions, add the remaining deductible, and check the out-of-pocket maximum. Ask the plan whether the stimulation sessions, the initial mapping session, and the supervising physician’s visits are each in network and each covered.

Is TMS covered by insurance?

Many commercial plans and Medicare contractors cover a course of TMS for major depressive disorder when written medical-necessity criteria are met, usually including prior antidepressant trials of adequate dose and duration, sometimes a psychotherapy trial, and prior authorization. Coverage is a plan-by-plan and policy-by-policy decision. Confirm in writing before the first session.

Does Medicare cover TMS?

There is no single national Medicare coverage determination for TMS. Coverage comes from Local Coverage Determinations issued by the regional Medicare Administrative Contractors, which set the diagnosis, treatment-history, ordering, and supervision rules. Under Original Medicare Part B you generally pay the annual Part B deductible ($283 in 2026) and then 20 percent of the Medicare-approved amount for each covered service. Medicare Advantage plans apply their own prior-authorization and cost-sharing rules.

How much do 36 sessions of TMS cost?

Thirty-six is the common insurer cap for an initial course: 30 sessions over about six weeks plus 6 taper sessions over about three weeks. The price of those sessions depends on whether you are paying a self-pay rate, an in-network negotiated rate, or a Medicare-approved amount, and on whether the first mapping session and any motor-threshold re-determinations are included. Ask the clinic to price the course as a whole and by session.

What is the cost of accelerated TMS or SAINT?

Accelerated and MRI-guided theta-burst protocols bill under separate category III codes (0889T through 0892T) and at least one major commercial policy lists accelerated and MRI-guided TMS, including SAINT, as experimental and investigational. That usually means self-pay unless a specific plan or Medicare pathway says otherwise. The SAINT-specific guide on this site covers what to verify for that protocol.

What disqualifies you from TMS?

Insurer and Medicare policies list exclusions such as a seizure disorder, ferromagnetic metal or implanted devices in or near the head, certain neurological conditions, current psychotic symptoms, and unstable medical illness. The FDA-cleared indication is for adults with major depressive disorder who did not improve on prior antidepressant treatment in the current episode; some policies now allow adolescents 15 and older. Only a treating clinician can determine candidacy.

Is TMS worth the cost, and is it a permanent fix?

No page can answer that for a specific person, and this guide does not promise outcomes. The consensus review from the Clinical TMS Society describes gradual benefit over a course of daily sessions for four to six weeks and describes reintroducing TMS for people who relapse after an initial response. Ask the clinician what response and relapse look like for people like you, what the plan is if you relapse, and whether retreatment would be covered.

What are the downsides of TMS?

NIMH lists discomfort at the site on the head where the magnet is placed, mild headaches, brief lightheadedness, and dizziness. Seizure is the most serious known risk; the Clinical TMS Society consensus review reports it as rare. The practical downsides are time (daily visits for weeks), travel, and cost if coverage is denied. Discuss risks with the treating clinician.

Primary and official sources

Check the underlying evidence and current policy language.

All sources were accessed September 5, 2026. The FDA order establishes the cleared device type and indication; it does not establish personal eligibility, coverage, price, or outcome. The Medicare payment figure is a published 2016 national average used in a peer-reviewed analysis and is cited as a benchmark, not a current price. Insurer policies and Medicare contractor determinations change; read the version in force on your date of service.